LYRA(Delisted)
Lyra Therapeutics·NASDAQ
--
--(--)
LYRA fundamentals
Lyra Therapeutics (LYRA) released its earnings on Aug 12, 2025: revenue was 191.50K (YoY -67.98%), missed estimates; EPS was -5.51 (YoY +85.11%), beat estimates.
Revenue / YoY
191.50K
-67.98%
EPS / YoY
-5.51
+85.11%
Report date
Aug 12, 2025
Earnings Call
4:00 PM on Aug 12, 2025
Meeting link.EPS
Actual | -27 | -28 | -24.5 | -26.9775 | -30 | -42.5 | -42.5 | -52.5 | -27 | -21.5 | -20 | -23 | -22 | -18 | -13.5 | -9.5 | -17.5 | -37 | -9 | -8 | -6.5 | -5.51 |
Forecast | -24.6667 | -18.8333 | -20.3333 | -27.9867 | -24.0133 | -29.6617 | -36.7925 | -39.4625 | -2.75 | -18.6425 | -22 | -20.702 | -18.25 | -21.1667 | -15.871 | -15.75 | -13.1058 | -16.715 | -10.75 | -6 | -7.5 | -5.5267 |
Surprise | -9.46% | -48.67% | -20.49% | +3.61% | -24.93% | -43.28% | -15.51% | -33.04% | -881.82% | -15.33% | +9.09% | -11.10% | -20.55% | +14.96% | +14.94% | +39.68% | -33.53% | -121.36% | +16.28% | -33.33% | +13.33% | +0.30% |
Revenue
Actual | 0 | 0 | 0 | 0 | 0 | 0 | 14.00K | 271.00K | 5.38M | 403.50K | 359.00K | 11.00K | 410.00K | 459.00K | 544.00K | 146.00K | 532.00K | 598.00K | 195.00K | 209.00K | 183.00K | 191.50K |
Forecast | 0 | 0 | 0 | 0 | 0 | 0 | 375.00K | 1.13M | 2.68M | 1.43M | 101.75K | 148.80K | 159.50K | 136.67K | 371.60K | 388.80K | 344.92K | 532.00K | 315.60K | 206.00K | 240.00K | 292.50K |
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -96.27% | -75.91% | +100.61% | -71.88% | +252.83% | -92.61% | +157.05% | +235.85% | +46.39% | -62.45% | +54.24% | +12.41% | -38.21% | +1.46% | -23.75% | -34.53% |
Earnings Call
No Data
You can ask Aime
No Data
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
